National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

VI. Design of Clinical Trials Working Group Report

Paul J. Martin, Daniel Weisdorf, Donna Przepiorka, Steven Hirschfeld, Ann Farrell, J. Douglas Rizzo, Ronan Foley, Gerard Socie, Shelly Carter, Daniel Couriel, Kirk R. Schultz, Mary E D Flowers, Alexandra H. Filipovich, Rima Saliba, Georgia Boyce Vogelsang, Steven Z. Pavletic, Stephanie J. Lee

Research output: Contribution to journalArticle

Abstract

The complexity of chronic graft-versus-host disease (GVHD) and the lack of established research methods have made it difficult to design, conduct, and analyze clinical trials involving subjects with this disease, even when promising treatment options are available. This consensus document was developed to offer an approach for overcoming these obstacles. Clinical trials in chronic GVHD should adhere to principles of good trial design and practice. Inclusion and exclusion criteria should allow as many subjects to participate as possible without compromising the interpretation of results. Pre-enrollment assessment of chronic GVHD characteristics should be standardized. The protocol should provide clear guidance about administration of study medication and other interventions. Methods of assessing response should be defined and validated in advance. Efficacy endpoints should be selected to reflect clinical benefit. Expert biostatistical support is needed to ensure the validity and reliability of trial results. The use of consistent standards in clinical trial designs to evaluate agents that have activity in pathogenic pathways could facilitate advances in the treatment of chronic GVHD.

Original languageEnglish (US)
Pages (from-to)491-505
Number of pages15
JournalBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Volume12
Issue number5
DOIs
StatePublished - May 2006

Fingerprint

National Institutes of Health (U.S.)
Graft vs Host Disease
Consensus
Clinical Trials
Reproducibility of Results
Research

Keywords

  • Allogeneic hematopoietic cell transplantation
  • Chronic graft-versus-host disease
  • Clinical trials
  • Consensus
  • Design

ASJC Scopus subject areas

  • Transplantation

Cite this

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease : VI. Design of Clinical Trials Working Group Report. / Martin, Paul J.; Weisdorf, Daniel; Przepiorka, Donna; Hirschfeld, Steven; Farrell, Ann; Rizzo, J. Douglas; Foley, Ronan; Socie, Gerard; Carter, Shelly; Couriel, Daniel; Schultz, Kirk R.; Flowers, Mary E D; Filipovich, Alexandra H.; Saliba, Rima; Vogelsang, Georgia Boyce; Pavletic, Steven Z.; Lee, Stephanie J.

In: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, Vol. 12, No. 5, 05.2006, p. 491-505.

Research output: Contribution to journalArticle

Martin, PJ, Weisdorf, D, Przepiorka, D, Hirschfeld, S, Farrell, A, Rizzo, JD, Foley, R, Socie, G, Carter, S, Couriel, D, Schultz, KR, Flowers, MED, Filipovich, AH, Saliba, R, Vogelsang, GB, Pavletic, SZ & Lee, SJ 2006, 'National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group Report', Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol. 12, no. 5, pp. 491-505. https://doi.org/10.1016/j.bbmt.2006.03.004
Martin, Paul J. ; Weisdorf, Daniel ; Przepiorka, Donna ; Hirschfeld, Steven ; Farrell, Ann ; Rizzo, J. Douglas ; Foley, Ronan ; Socie, Gerard ; Carter, Shelly ; Couriel, Daniel ; Schultz, Kirk R. ; Flowers, Mary E D ; Filipovich, Alexandra H. ; Saliba, Rima ; Vogelsang, Georgia Boyce ; Pavletic, Steven Z. ; Lee, Stephanie J. / National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease : VI. Design of Clinical Trials Working Group Report. In: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2006 ; Vol. 12, No. 5. pp. 491-505.
@article{0ed42d0e1b3f4d5e9f5af183efcc41c0,
title = "National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group Report",
abstract = "The complexity of chronic graft-versus-host disease (GVHD) and the lack of established research methods have made it difficult to design, conduct, and analyze clinical trials involving subjects with this disease, even when promising treatment options are available. This consensus document was developed to offer an approach for overcoming these obstacles. Clinical trials in chronic GVHD should adhere to principles of good trial design and practice. Inclusion and exclusion criteria should allow as many subjects to participate as possible without compromising the interpretation of results. Pre-enrollment assessment of chronic GVHD characteristics should be standardized. The protocol should provide clear guidance about administration of study medication and other interventions. Methods of assessing response should be defined and validated in advance. Efficacy endpoints should be selected to reflect clinical benefit. Expert biostatistical support is needed to ensure the validity and reliability of trial results. The use of consistent standards in clinical trial designs to evaluate agents that have activity in pathogenic pathways could facilitate advances in the treatment of chronic GVHD.",
keywords = "Allogeneic hematopoietic cell transplantation, Chronic graft-versus-host disease, Clinical trials, Consensus, Design",
author = "Martin, {Paul J.} and Daniel Weisdorf and Donna Przepiorka and Steven Hirschfeld and Ann Farrell and Rizzo, {J. Douglas} and Ronan Foley and Gerard Socie and Shelly Carter and Daniel Couriel and Schultz, {Kirk R.} and Flowers, {Mary E D} and Filipovich, {Alexandra H.} and Rima Saliba and Vogelsang, {Georgia Boyce} and Pavletic, {Steven Z.} and Lee, {Stephanie J.}",
year = "2006",
month = "5",
doi = "10.1016/j.bbmt.2006.03.004",
language = "English (US)",
volume = "12",
pages = "491--505",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

T2 - VI. Design of Clinical Trials Working Group Report

AU - Martin, Paul J.

AU - Weisdorf, Daniel

AU - Przepiorka, Donna

AU - Hirschfeld, Steven

AU - Farrell, Ann

AU - Rizzo, J. Douglas

AU - Foley, Ronan

AU - Socie, Gerard

AU - Carter, Shelly

AU - Couriel, Daniel

AU - Schultz, Kirk R.

AU - Flowers, Mary E D

AU - Filipovich, Alexandra H.

AU - Saliba, Rima

AU - Vogelsang, Georgia Boyce

AU - Pavletic, Steven Z.

AU - Lee, Stephanie J.

PY - 2006/5

Y1 - 2006/5

N2 - The complexity of chronic graft-versus-host disease (GVHD) and the lack of established research methods have made it difficult to design, conduct, and analyze clinical trials involving subjects with this disease, even when promising treatment options are available. This consensus document was developed to offer an approach for overcoming these obstacles. Clinical trials in chronic GVHD should adhere to principles of good trial design and practice. Inclusion and exclusion criteria should allow as many subjects to participate as possible without compromising the interpretation of results. Pre-enrollment assessment of chronic GVHD characteristics should be standardized. The protocol should provide clear guidance about administration of study medication and other interventions. Methods of assessing response should be defined and validated in advance. Efficacy endpoints should be selected to reflect clinical benefit. Expert biostatistical support is needed to ensure the validity and reliability of trial results. The use of consistent standards in clinical trial designs to evaluate agents that have activity in pathogenic pathways could facilitate advances in the treatment of chronic GVHD.

AB - The complexity of chronic graft-versus-host disease (GVHD) and the lack of established research methods have made it difficult to design, conduct, and analyze clinical trials involving subjects with this disease, even when promising treatment options are available. This consensus document was developed to offer an approach for overcoming these obstacles. Clinical trials in chronic GVHD should adhere to principles of good trial design and practice. Inclusion and exclusion criteria should allow as many subjects to participate as possible without compromising the interpretation of results. Pre-enrollment assessment of chronic GVHD characteristics should be standardized. The protocol should provide clear guidance about administration of study medication and other interventions. Methods of assessing response should be defined and validated in advance. Efficacy endpoints should be selected to reflect clinical benefit. Expert biostatistical support is needed to ensure the validity and reliability of trial results. The use of consistent standards in clinical trial designs to evaluate agents that have activity in pathogenic pathways could facilitate advances in the treatment of chronic GVHD.

KW - Allogeneic hematopoietic cell transplantation

KW - Chronic graft-versus-host disease

KW - Clinical trials

KW - Consensus

KW - Design

UR - http://www.scopus.com/inward/record.url?scp=33745447476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745447476&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2006.03.004

DO - 10.1016/j.bbmt.2006.03.004

M3 - Article

VL - 12

SP - 491

EP - 505

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 5

ER -